Dianxiang Lu

838 total citations
44 papers, 607 citations indexed

About

Dianxiang Lu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Dianxiang Lu has authored 44 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Dianxiang Lu's work include Pulmonary Hypertension Research and Treatments (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and High Altitude and Hypoxia (10 papers). Dianxiang Lu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (16 papers), Eicosanoids and Hypertension Pharmacology (11 papers) and High Altitude and Hypoxia (10 papers). Dianxiang Lu collaborates with scholars based in China and United States. Dianxiang Lu's co-authors include Zhanqiang Li, Shanshan Su, Ri‐Li Ge, Zhongwei Gu, Yujiang Fan, Jie Liang, Xingdong Zhang, Xiantao Wen, Lan Ma and Dipak K. Das and has published in prestigious journals such as PLoS ONE, Journal of Ethnopharmacology and European Journal of Pharmacology.

In The Last Decade

Dianxiang Lu

39 papers receiving 598 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dianxiang Lu China 16 212 131 94 91 71 44 607
Jiuxin Zhu China 17 311 1.5× 105 0.8× 41 0.4× 29 0.3× 124 1.7× 30 762
Blerina Ahmetaj‐Shala United Kingdom 14 177 0.8× 88 0.7× 29 0.3× 45 0.5× 93 1.3× 33 653
Saeed Nazari Soltan Ahmad Iran 19 293 1.4× 37 0.3× 54 0.6× 33 0.4× 75 1.1× 32 754
Yuqian Cui China 16 225 1.1× 43 0.3× 87 0.9× 33 0.4× 56 0.8× 31 731
Bo Qian China 16 422 2.0× 62 0.5× 27 0.3× 48 0.5× 68 1.0× 45 794
Fereshteh Asgharzadeh Iran 16 232 1.1× 64 0.5× 103 1.1× 36 0.4× 75 1.1× 73 868
Ting Jiang China 13 271 1.3× 33 0.3× 44 0.5× 36 0.4× 46 0.6× 30 673
Ruiyan Pan China 17 249 1.2× 39 0.3× 72 0.8× 31 0.3× 43 0.6× 42 577
Jia Gu China 15 307 1.4× 48 0.4× 29 0.3× 66 0.7× 29 0.4× 28 747
Conghui Liu China 10 339 1.6× 38 0.3× 126 1.3× 20 0.2× 47 0.7× 15 788

Countries citing papers authored by Dianxiang Lu

Since Specialization
Citations

This map shows the geographic impact of Dianxiang Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dianxiang Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dianxiang Lu more than expected).

Fields of papers citing papers by Dianxiang Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dianxiang Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dianxiang Lu. The network helps show where Dianxiang Lu may publish in the future.

Co-authorship network of co-authors of Dianxiang Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Dianxiang Lu. A scholar is included among the top collaborators of Dianxiang Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dianxiang Lu. Dianxiang Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hou, Bin, Shanshan Su, Lei Ji, et al.. (2025). Luteolin alleviates right ventricular hypertrophy in high altitude pulmonary hypertension rats by regulating PI3K/AKT/mTOR signalling pathway. European Journal of Pharmacology. 1003. 177898–177898.
2.
Feng, Yuning, Wenyao Cui, Liyuan Peng, et al.. (2025). Elevated neutrophil to high-density lipoprotein ratio predicts pneumonia in patients with intracerebral hemorrhage. Frontiers in Medicine. 12. 1572131–1572131.
3.
Zhang, Zhaoxia, Chen Ju, Shanshan Su, et al.. (2024). Luteolin ameliorates hypoxic pulmonary vascular remodeling in rat via upregulating KV1.5 of pulmonary artery smooth muscle cells. Phytomedicine. 132. 155840–155840. 5 indexed citations
4.
Su, Shanshan, et al.. (2023). 4-Terpineol attenuates pulmonary vascular remodeling via suppressing PI3K/Akt signaling pathway in hypoxia-induced pulmonary hypertension rats. Toxicology and Applied Pharmacology. 473. 116596–116596. 3 indexed citations
5.
Su, Shanshan, et al.. (2023). Kaempferol ameliorates pulmonary vascular remodeling in chronic hypoxia-induced pulmonary hypertension rats via regulating Akt-GSK3β-cyclin axis. Toxicology and Applied Pharmacology. 466. 116478–116478. 9 indexed citations
6.
7.
Su, Shanshan, et al.. (2022). The Mechanism of Volatile Oil of Rhodiola tangutica against Hypoxia‐Induced Pulmonary Hypertension in Rats Based on RAS Pathway. BioMed Research International. 2022(1). 9650650–9650650. 6 indexed citations
8.
Yang, Mei, et al.. (2022). Mechanism of Traditional Tibetan Medicine Grubthobrildkr Alleviated Gastric Ulcer Induced by Acute Systemic Hypoxia in Rats. BioMed Research International. 2022(1). 4803956–4803956. 3 indexed citations
9.
Su, Shanshan, et al.. (2021). Tsantan Sumtang Restored Right Ventricular Function in Chronic Hypoxia-Induced Pulmonary Hypertension Rats. Frontiers in Pharmacology. 11. 607384–607384. 16 indexed citations
10.
Zhang, Ruixia, Zhanqiang Li, Chuanchuan Liu, et al.. (2021). Pretreatment with the active fraction of Rhodiola tangutica (Maxim.) S.H. Fu rescues hypoxia-induced potassium channel inhibition in rat pulmonary artery smooth muscle cells. Journal of Ethnopharmacology. 283. 114734–114734. 6 indexed citations
11.
Wang, Tingting, Jinzhi Zhang, Guanlan Fan, et al.. (2021). MiR-17-5p/FOXL2/CDKN1B signal programming in oocytes mediates transgenerational inheritance of diminished ovarian reserve in female offspring rats induced by prenatal dexamethasone exposure. Cell Biology and Toxicology. 39(3). 867–883. 8 indexed citations
12.
Zhang, Xiaoyan, et al.. (2020). Cognitive Protective Mechanism of Crocin Pretreatment in Rat Submitted to Acute High‐Altitude Hypoxia Exposure. BioMed Research International. 2020(1). 3409679–3409679. 22 indexed citations
13.
14.
15.
Su, Shanshan, Xiaodong Ma, Ximeng Wang, et al.. (2018). Bioactive fraction of Rhodiola algida against chronic hypoxia-induced pulmonary arterial hypertension and its anti-proliferation mechanism in rats. Journal of Ethnopharmacology. 216. 175–183. 37 indexed citations
16.
17.
Zhang, Wei, Tana Wuren, Yaping Wang, et al.. (2015). Echinacoside induces rat pulmonary artery vasorelaxation by opening the NO-cGMP-PKG-BKCa channels and reducing intracellular Ca2+ levels. Acta Pharmacologica Sinica. 36(5). 587–596. 21 indexed citations
18.
Tang, Feng, Jing Ma, Shenglan Wang, et al.. (2014). Antiproliferative Effect of Echinacoside on Rat Pulmonary Artery Smooth Muscle Cells Under Hypoxia. Journal of Pharmacological Sciences. 126(2). 155–163. 12 indexed citations
19.
Yang, Mei, Shuna Zhang, Jin‐Jun Wang, et al.. (2013). Effect of aqueous extract of Sanweitanxiang powder on calcium homeostasis protein expression in ischemic-reperfusion injury rat heart. Journal of Traditional Chinese Medicine. 33(3). 355–360. 4 indexed citations
20.
Lu, Dianxiang, et al.. (2011). The Study of Cytostatic Effect on MCF-7 Cells of the Alcohol Extract of Rhodiola Algida Var. Tangutica. Procedia Environmental Sciences. 8. 615–619. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiuxin Zhu Breakdown of academic impact, for papers by Blerina Ahmetaj‐Shala Breakdown of academic impact, for papers by Saeed Nazari Soltan Ahmad Breakdown of academic impact, for papers by Yuqian Cui Breakdown of academic impact, for papers by Bo Qian Breakdown of academic impact, for papers by Fereshteh Asgharzadeh Breakdown of academic impact, for papers by Ting Jiang Breakdown of academic impact, for papers by Ruiyan Pan Breakdown of academic impact, for papers by Jia Gu Breakdown of academic impact, for papers by Conghui Liu
Rankless by CCL
2026